Biosystems S.A. · Class II · Cleared May 2, 2019
| K-number | K182474 |
| Device name | alpha-AMYLASE DIRECT, alpha-AMYLASE EPS, alpha-AMYLASE PANCREATIC, BILIRUBIN DIRECT, BILIRUBIN TOTAL |
| Applicant | Biosystems S.A. |
| Product code | JFJ |
| Device class | Class II |
| Decision date | May 2, 2019 |
| Decision | Substantially Equivalent |
| Regulation | 862.1070 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov